Single-arm, open label, clinical trial of cabazitaxel to assess safety and efficacy in Japanese patients with castration resistant prostate cancer (CRPC) previously treated with a docetaxel-containing regimen

Trial Profile

Single-arm, open label, clinical trial of cabazitaxel to assess safety and efficacy in Japanese patients with castration resistant prostate cancer (CRPC) previously treated with a docetaxel-containing regimen

Completed
Phase of Trial: Phase II

Latest Information Update: 18 May 2016

At a glance

  • Drugs Cabazitaxel (Primary) ; Prednisolone
  • Indications Prostate cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 20 Apr 2015 Status changed from active, no longer recruiting to completed, according to University Hospital Medical Information Network - Japan
    • 17 Sep 2014 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
    • 22 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top